BiotechTube
Home/Hepta/Hamed Amini, Ph.D.
HA

Hamed Amini, Ph.D.

CEO & Co-Founder

Hepta

Therapeutic Areas

Metabolic DiseaseHepatology

Hepta Pipeline

DrugIndicationPhase
Liquid Biopsy for MASHMetabolic dysfunction-associated steatohepatitis (MASH) detection and stagingPre-clinical

Leadership Team at Hepta

SD
Soheil Damangir, Ph.D.
CTO & Co-Founder
RL
Rohit Loomba, M.D., M.H.Sc.
Chief Medical & Scientific Advisor
View full Hepta profile